Case | Gender | Age | Reconstruction methods | Surgical margin | Pathological diagnosis | Stage | Resection type | Intervention operation | Blood loss (ml) | Complications | LLD(cm) | Follow-up (months) | MSTS score | Harris score | Recurrence metastasis | Patient status |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Male | 54 | NAHP | Wide | Angiosarcoma | IIB | I + II | YES | 1200 | Infection | 1 | 21 | 20 | 80 | Recurrence | DOD |
2 | Male | 65 | NAHP | Wide | Metastatic lung adenocarcinoma | III | II + III | YES | 1400 | 1 | 26 | 17 | 66 | AWD | ||
3 | Male | 46 | NAHP | Marginal | Angiosarcoma | IIB | I + II | YES | 2500 | Pulmonary | 1.5 | 27 | 19 | 77 | NED | |
4 | Female | 53 | NAHP | Wide | Chondrosarcoma | IIB | I + II | YES | 1200 | Infection | 1 | 23 | 23 | 83 | NED | |
5 | Female | 56 | NAHP | Wide | Mesenchymal malignancy | IIB | I + II | YES | 1000 | 1 | 21 | 22 | 85 | NED | ||
6 | Female | 38 | MHP | Marginal | mesenchymal malignancy | IIB | I + II + III | NO | 2000 | Cutaneous necrosis | 1.5 | 20 | 15 | 57 | Lung Metastasis | DOD |
7 | Male | 33 | MHP | Wide | MGCT | IIB | II | NO | 1500 | 1 | 58 | 23 | 87 | NED | ||
8 | Female | 51 | MHP | Wide | Chondrosarcoma | IIB | II + III | NO | 2600 | 1 | 19 | 19 | 76 | Recurrence | DOD | |
9 | Male | 35 | MHP | Marginal | MGCT | IIB | II + III | NO | 3200 | 2 | 46 | 14 | 53 | NED | ||
10 | Male | 28 | MHP | Wide | Synovial sarcoma | IIB | I + II + III | NO | 2100 | Dislocation | 2.5 | 52 | 22 | 84 | NED | |
11 | Male | 34 | MHP | Wide | Invasive chondroblastoma | IIB | II + III | NO | 5000 | Wound dehiscence | 2 | 45 | 20 | 77 | NED | |
12 | Female | 45 | MHP | Wide | Chondrosarcoma | IIB | II + III | NO | 4800 | Wound dehiscence | 1 | 26 | 18 | 73 | NED | |
13 | Female | 27 | MHP | Wide | Chondrosarcoma | IIB | II + III | NO | 2700 | 1.5 | 28 | 18 | 76 | NED | ||
14 | Female | 50 | MHP | Wide | Chondrosarcoma | IIB | II + III | NO | 2500 | 1 | 19 | 21 | 83 | NED | ||
15 | Male | 45 | MHP | Wide | MGCT | IIB | I + II + III | NO | 8000 | Infection | NA | 36 | 10 | 56 | NED | |
Tension blisters | ||||||||||||||||
HA | ||||||||||||||||
16 | Male | 37 | MHP | Wide | fibrosarcoma | IIB | I + II | NO | 5000 | 1 | 37 | 23 | 85 | NED | ||
17 | Male | 45 | MHP | Wide | MGCT | IIB | II + III | YES | 2300 | 1.5 | 47 | 20 | 78 | NED | ||
18 | Male | 48 | S-RHP | Marginal | Angiosarcoma | IIB | I + II | NO | 3200 | Infection | 1 | 26 | 18 | 75 | Recurrence | DOD |
19 | Male | 57 | S-RHP | Wide | Chondrosarcoma | IIB | I + II | NO | 3700 | Wound dehiscence | 1.5 | 25 | 14 | 56 | NED | |
20 | Male | 75 | S-RHP | Marginal | chondrosarcoma | IIB | I + II | YES | 3000 | Infection | 2 | 18 | 17 | 72 | Recurrence | DOD |
Dislocation | Lung Metastasis | |||||||||||||||
Urinary retention | ||||||||||||||||
Thrombosis | ||||||||||||||||
21 | Male | 61 | S-RHP | Wide | chondrosarcoma | IIB | I + II | NO | 2600 | Dislocation | 1 | 20 | 15 | 61 | Recurrence | DOD |
22 | Female | 21 | S-RHP | Wide | chondrosarcoma | IB | I + II | NO | 1200 | 1.5 | 38 | 19 | 80 | NED | ||
23 | Male | 21 | S-RHP | Wide | osteosarcoma | IIB | I + II | NO | 2000 | 1.5 | 21 | 20 | 76 | Recurrence | DOD | |
Lung Metastasis |